Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...
M223, a preclinical drug for inflammatory diseases, with potential milestone payments of $777.5M plus royalties.
Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion on new therapies and the role of diet.
The severity of a patient’s chronic spontaneous urticaria impacted several outcomes, including quality of life and treatment ...
In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...
Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria ...
Novartis is further bolstering its preclinical pipeline and continuing its hunt for a Xolair successor, nailing down a ...
Verywell Health on MSN3d
Xyzal vs. Zyrtec: How Do They Compare for Allergies?Xyzal (levocetirizine) and Zyrtec (cetirizine) are over-the-counter (OTC) allergy medications. Learn about their key ...
Remibrutinib significantly reduces itch and hives in patients with chronic spontaneous urticaria in two identical randomized ...
For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, ...
A new groundbreaking study revealed that Remibrutinib showed promising results in treating chronic spontaneous urticaria.A recent study published in the New England Journal of Medicine outlined the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback